Stock AQST AQUESTIVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Aquestive Therapeutics, Inc.

Equities

AQST

US03843E1047

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
3.15 USD -0.94% Intraday chart for Aquestive Therapeutics, Inc. -2.17% +55.94%
May. 10 Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target MT
May. 08 Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aquestive Therapeutics, Inc. Appoints Abigail Jenkins to Board of Directors, Effective April 1, 2024
CI
Aquestive Therapeutics Submits NDA for Libervant for Pediatric Population; Names New Chief Medical Officer
MT
Aquestive Therapeutics, Inc. Names Carl N. Kraus as Chief Medical Officer
CI
Aquestive Therapeutics Receives Conditional FDA Acceptance of Proprietary Name Anaphylm for Lead Candidate AQST-109 (Epinephrine Sublingual Film)
CI
Aquestive Therapeutics, Inc. Announces the Appointment of Scientific Advisory Board
CI
Aquestive Therapeutics, Inc. Announces Management Changes
CI
Aquestive Therapeutics Names New CEO
MT
Aquestive Therapeutics, Inc. Announces Management Changes
CI
Aquestive Therapeutics, Inc. Announces Executive Changes
CI
Aquestive Therapeutics, Inc. Appoints A. Ernest Toth, Jr. as Senior Vice President
CI
Insider Trends: 90-Day Insider Selling Trend Prolonged at Aquestive Therapeutics
MT
Insider Trends: Insider Sales Add to 90-Day Trend at Aquestive Therapeutics
MT
Aquestive Therapeutics, Inc. Announces Executive Changes
CI
Aquestive Therapeutics, Inc. Appoints Mark Lepore as Chief Medical Officer for Allergy
CI
Aquestive Therapeutics, Inc. Announces Resignation of John Maxwell as Senior Vice President
CI
Aquestive Therapeutics : Announces Daniel Barber Named to Chief Operating Officer
PR
Aquestive Therapeutics, Inc. Appoints Daniel Barber to the New Position of Senior Vice President, Chief Operating Officer
CI
Aquestive Therapeutics, Inc. Appoints Gary H. Slatko as SVP, Chief Medical Officer
CI
Aquestive Therapeutics, Inc. Names Lori J. Braender, Esq. as Senior Vice President, General Counsel
CI
Aquestive Therapeutics, Inc. Names Sandy Costa as Chairman of the Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AQST Stock
  4. News Aquestive Therapeutics, Inc.
  5. Insiders